Financhill
Sell
21

MED Quote, Financials, Valuation and Earnings

Last price:
$11.05
Seasonality move :
15.75%
Day range:
$11.02 - $11.37
52-week range:
$10.36 - $18.59
Dividend yield:
0%
P/E ratio:
528.23x
P/S ratio:
0.28x
P/B ratio:
0.57x
Volume:
336.1K
Avg. volume:
265K
1-year change:
-37.84%
Market cap:
$121.3M
Revenue:
$602.5M
EPS (TTM):
$0.02

Earnings Data

Next earnings date for MED
Feb 19
2026
Most recent earnings per share
-$0.21
Beat by $0.15
(Nov 3/2025)
Consensus Estimate
-$0.36
(Nov 3/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MED Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/19/2026 Q4 $71.4M -- -- -$0.82 --
11/03/2025 Q3 $89.7M $89.4M -$0.21 -$0.36 $0.15
08/04/2025 Q2 $101.8M $105.6M $0.22 -$0.19 $0.41
04/28/2025 Q1 $116.4M $115.7M -$0.07 -$0.25 $0.18
02/18/2025 Q4 $114.3M $119M $0.07 -$0.16 $0.23
11/04/2024 Q3 $138.2M $140.2M $0.10 -$0.19 $0.29
08/05/2024 Q2 $174.1M $168.6M -$0.75 $0.39 -$1.14
04/29/2024 Q1 $173.5M $174.7M $0.76 $0.80 -$0.04
02/20/2024 Q4 $184.2M $191M $0.55 $0.96 -$0.41
11/06/2023 Q3 -- $235.9M $2.12 -- --
08/07/2023 Q2 -- $296.2M $2.77 -- --
05/01/2023 Q1 -- $349M $3.67 -- --
02/21/2023 Q4 -- $337.2M $2.41 -- --
11/03/2022 Q3 -- $390.4M $3.27 -- --
08/03/2022 Q2 -- $453.3M $3.42 -- --
05/02/2022 Q1 -- $417.6M $3.59 -- --
02/23/2022 Q4 -- $377.8M $2.91 -- --
11/04/2021 Q3 -- $413.4M $3.56 -- --
08/04/2021 Q2 -- $394.2M $3.96 -- --
05/04/2021 Q1 -- $340.7M $3.46 -- --
02/25/2021 Q4 -- $264.9M $2.36 -- --
11/02/2020 Q3 -- $271.5M $2.91 -- --
08/05/2020 Q2 -- $220M $1.86 -- --
05/05/2020 Q1 -- $178.5M $1.56 -- --
02/26/2020 Q4 -- $170.6M $1.66 -- --
11/07/2019 Q3 -- $190.1M $1.32 -- --
08/01/2019 Q2 -- $187.1M $1.75 -- --
05/01/2019 Q1 -- $165.9M $1.70 -- --
02/26/2019 Q4 -- $145.8M $1.30 -- --
11/06/2018 Q3 -- $139.2M $1.14 -- --
08/02/2018 Q2 -- $117.3M $1.16 -- --
05/03/2018 Q1 -- $98.6M $1.01 -- --
03/06/2018 Q4 -- $78M $0.60 -- --
11/07/2017 Q3 -- $77.2M $0.55 -- --
08/08/2017 Q2 -- $75.7M $0.63 -- --
05/04/2017 Q1 -- $70.6M $0.51 -- --
03/09/2017 Q4 -- $62.5M $0.34 -- --
11/03/2016 Q3 -- $68.6M $0.51 -- --
08/03/2016 Q2 -- $71.1M $0.29 -- --
05/04/2016 Q1 -- $72.3M $0.36 -- --
03/10/2016 Q4 -- $61.3M $0.32 -- --

Medifast, Inc. Earnings Questions

  • How Much did Medifast, Inc. Generate in Revenue Last Quarter?

    Medifast, Inc. reported $89.4M worth of top line sales in its most recent quarter.

  • Did Medifast, Inc. Beat Earnings Last Quarter?

    Medifast, Inc. announced earnings per share of -$0.21 which represents a beat of analyst forecast a -$0.36 per share.

  • Is Medifast, Inc. Profitable?

    Medifast, Inc. reported $62.2M that represents $5.66 per share over the last quarter.

  • What is the Analyst Consensus for Medifast, Inc. EPS Next Year?

    Medifast, Inc.'s earnings are forecast to grow from $0.19 per share to -$0.12 per share next year representing an increase of 57.32%.

  • When is Medifast, Inc.'s Earnings Date?

    Medifast, Inc.'s next earnings date is February 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock